| 2023年年报 | 2023年中报 | 2022年年报 | 2022年中报 | |
|---|---|---|---|---|
| 营业收入(元) | ||||
| 精神类(元) | 1,091,851,591.80 | 550,442,908.80 | 1,052,496,699.30 | 539,738,375.65 |
| 麻醉类(元) | 2,702,286,545.08 | 1,268,265,204.08 | 2,174,168,494.87 | 977,977,209.59 |
| 神经类(元) | 126,595,091.70 | 73,729,641.73 | 186,784,525.70 | 84,120,626.44 |
| 原料药(元) | 145,572,476.05 | 75,553,570.10 | 117,427,370.60 | 62,975,892.67 |
| 商业医药(元) | 708,519,568.73 | 290,022,639.53 | 516,227,371.26 | 227,924,210.16 |
| 其他主营业务(元) | - | - | - | 227,924,210.16 |
| 其他贸易及劳务(元) | 47,113,658.52 | 26,385,970.94 | 64,239,755.01 | 37,427,994.17 |
| 其他销售(元) | - | 91,739,385.87 | - | 55,583,161.84 |
| 其他业务(元) | - | - | - | 15,351,496.38 |
| 其他制剂(元) | 153,931,677.41 | - | 143,683,069.96 | - |
| 营业成本(元) | ||||
| 精神类(元) | 251,388,619.41 | 111,500,861.60 | 178,401,061.51 | 92,721,842.11 |
| 麻醉类(元) | 315,565,954.48 | 151,381,092.94 | 214,575,233.72 | 98,114,598.57 |
| 神经类(元) | 38,511,359.89 | 26,112,049.29 | 40,633,823.86 | 20,641,110.85 |
| 原料药(元) | 91,953,016.55 | 44,365,784.61 | 62,967,012.38 | - |
| 商业医药(元) | 585,833,644.43 | 241,742,224.35 | 429,395,228.57 | - |
| 其他主营业务(元) | - | - | - | - |
| 其他贸易及劳务(元) | 14,120,253.68 | 8,834,367.44 | 34,798,486.70 | - |
| 其他销售(元) | - | 39,458,001.91 | - | - |
| 其他业务(元) | - | - | - | 4,436,752.63 |
| 其他制剂(元) | 58,329,200.59 | - | 50,091,771.26 | - |
| 毛利(元) | ||||
| 精神类(元) | 840,462,972.39 | 438,942,047.20 | 874,095,637.79 | 447,016,533.54 |
| 麻醉类(元) | 2,386,720,590.60 | 1,116,884,111.14 | 1,959,593,261.15 | 879,862,611.02 |
| 神经类(元) | 88,083,731.81 | 47,617,592.44 | 146,150,701.84 | 63,479,515.59 |
| 原料药(元) | 53,619,459.50 | 31,187,785.49 | 54,460,358.22 | - |
| 商业医药(元) | 122,685,924.30 | 48,280,415.18 | 86,832,142.69 | - |
| 其他主营业务(元) | - | - | - | - |
| 其他贸易及劳务(元) | 32,993,404.84 | 17,551,603.50 | 29,441,268.31 | - |
| 其他销售(元) | - | 52,281,383.96 | - | - |
| 其他业务(元) | - | - | - | 10,914,743.75 |
| 其他制剂(元) | 95,602,476.82 | - | 93,591,298.70 | - |
| 毛利率(%) | ||||
| 精神类(%) | 76.98 | 79.74 | 83.05 | 82.82 |
| 麻醉类(%) | 88.32 | 88.06 | 90.13 | 89.97 |
| 神经类(%) | 69.58 | 64.58 | 78.25 | 75.46 |
| 原料药(%) | 36.83 | 41.28 | 46.38 | - |
| 商业医药(%) | 17.32 | 16.65 | 16.82 | - |
| 其他主营业务(%) | - | - | - | - |
| 其他贸易及劳务(%) | 70.03 | 66.52 | 45.83 | - |
| 其他销售(%) | - | 56.99 | - | - |
| 其他业务(%) | - | - | - | 71.10 |
| 其他制剂(%) | 62.11 | - | 65.14 | - |
| 收入构成(%) | ||||
| 精神类(%) | 21.94 | 23.17 | 24.74 | 24.21 |
| 麻醉类(%) | 54.31 | 53.38 | 51.10 | 43.87 |
| 神经类(%) | 2.54 | 3.10 | 4.39 | 3.77 |
| 原料药(%) | 2.93 | 3.18 | 2.76 | 2.83 |
| 商业医药(%) | 14.24 | 12.21 | 12.13 | 10.23 |
| 其他主营业务(%) | - | - | - | 10.23 |
| 其他贸易及劳务(%) | 0.95 | 1.11 | 1.51 | 1.68 |
| 其他销售(%) | - | 3.86 | - | 2.49 |
| 其他业务(%) | - | - | - | 0.69 |
| 其他制剂(%) | 3.09 | - | 3.38 | - |
| 毛利构成(%) | ||||
| 精神类(%) | 23.22 | 25.04 | 26.94 | 31.90 |
| 麻醉类(%) | 65.93 | 63.72 | 60.40 | 62.79 |
| 神经类(%) | 2.43 | 2.72 | 4.51 | 4.53 |
| 原料药(%) | 1.48 | 1.78 | 1.68 | 0.00 |
| 商业医药(%) | 3.39 | 2.75 | 2.68 | 0.00 |
| 其他主营业务(%) | - | - | - | 0.00 |
| 其他贸易及劳务(%) | 0.91 | 1.00 | 0.91 | 0.00 |
| 其他销售(%) | - | 2.98 | - | 0.00 |
| 其他业务(%) | - | - | - | 0.78 |
| 其他制剂(%) | 2.64 | - | 2.88 | - |